<div id="readability-page-1"><p>Leibman Financial Services Inc. lessened its holdings in shares of  Albemarle Corporation (NYSE:ALB - Free Report) by 33.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 32,364 shares of the specialty chemicals company's stock after selling 16,507 shares during the period. Albemarle accounts for approximately  2.0% of Leibman Financial Services Inc.'s holdings, making the stock its 21st biggest position. Leibman Financial Services Inc.'s holdings in Albemarle were worth $2,624,000 at the end of the most recent quarter.</p><ul><li>3 Signals Pointing to a Turnaround for Albemarle</li></ul><p>A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. CWM LLC boosted its stake in shares of  Albemarle by 14.8% during the 3rd quarter. CWM LLC now owns 165,074 shares of the specialty chemicals company's stock worth $13,384,000 after acquiring an additional 21,257 shares during the last quarter.  Empower Advisory Group LLC lifted its position in  Albemarle by 11.4% during the second quarter. Empower Advisory Group LLC now owns 866,575 shares of the specialty chemicals company's stock valued at $54,308,000 after purchasing an additional 88,457 shares in the last quarter.  AXQ Capital LP purchased a new position in  Albemarle during the second quarter valued at $267,000.  Bard Financial Services Inc. bought a new stake in  Albemarle during the second quarter valued at about $1,850,000.  Finally, Teza Capital Management LLC purchased a new stake in  Albemarle in the first quarter worth about $764,000. Institutional investors own  92.87% of the company's stock. </p><h2>Wall Street Analysts Forecast Growth</h2><p>ALB has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on Albemarle from $110.00 to $125.00 and gave the company a &#34;hold&#34; rating in a research note on Wednesday, December 3rd. Wells Fargo &amp; Company upped their price target on shares of Albemarle from $100.00 to $135.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Friday, December 19th. Argus raised their price objective on shares of Albemarle from $120.00 to $140.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, November 17th. Truist Financial  set a $125.00 target price on shares of Albemarle in a report on Wednesday, December 17th. Finally, TD Cowen raised their price target on Albemarle from $70.00 to $85.00 and gave the company a &#34;hold&#34; rating in a report on Thursday, October 9th. One equities research analyst  has rated the stock with a Strong Buy rating, nine have given a Buy rating, eighteen have issued  a Hold rating and two have issued  a Sell rating to the company's stock. According to data from MarketBeat.com, the stock  has a consensus rating of &#34;Hold&#34; and an average target price of $120.21.</p><ul><li>5 Surprising Stocks Set to Benefit From a Future Robotics Boom</li></ul><p><b>View Our Latest Analysis on ALB</b></p><h2>Albemarle Trading Down 3.6%</h2><p>Shares of ALB stock opened at $144.58 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 1.51 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $17.02 billion, a price-to-earnings ratio of -90.93 and a beta of 1.42. Albemarle Corporation has a 12-month low of $49.43 and a 12-month high of $152.08. The stock's 50-day moving average price is $119.18 and its 200-day moving average price is $92.05. </p><ul><li>5 EV Battery and Lithium Stocks Charging the Future</li></ul><p>Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.92) by $0.73. Albemarle had a positive return on equity of 0.10% and a negative net margin of 0.43%.The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the company posted ($1.55) EPS. The company's revenue was down 3.5% compared to the same quarter last year.  Equities research analysts predict that  Albemarle Corporation will post -0.04 EPS for the current fiscal year. </p><h2>Albemarle Announces Dividend</h2><p>The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Friday, December 12th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $1.62 annualized dividend and a dividend yield of 1.1%. Albemarle's payout ratio is currently -101.89%. </p><h2>Albemarle Company Profile</h2> (Free Report)<p>Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company's bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.  </p><p>Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world's foremost chemical producers.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Albemarle</li><li>Wall Street Stockpicker Names #1 Stock of 2026</li><li>Do not delete, read immediately</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Your “birthright claim” just got activated</li><li>Buy this $2 Gold Stock Before January 1, 2026</li></ul><p><strong>Want to see what other hedge funds are holding ALB?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFMQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFMQg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Albemarle Right Now?</h2><p>Before you consider Albemarle, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.</p><p>While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Leibman Financial Services Inc. reduced its stake in Albemarle Corporation (NYSE:ALB) by 33.8%, selling 16,507 shares during Q3. The firm now holds 32,364 shares, valued at $2.62 million, making it Albemarle's 21st largest position. Other institutional investors have also adjusted their stakes, with CWM LLC increasing its holdings by 14.8%. Analysts have raised price targets for Albemarle, with a consensus rating of "Hold" and an average target price of $120.21. The company recently reported earnings of ($0.19) EPS, exceeding estimates, and announced a quarterly dividend of $0.405 per share.</p>

Leibman Financial Services Inc. Sells 16,507 Shares of Albemarle Corporation $ALB